Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: A follow-on study to a randomized clinical trial

Background: In a previous study, 60 infants receiving an investigational serogroup B meningococcal vaccine containing recombinant meningococcal proteins alone (rMenB) or combined with an outer membrane vesicle from Neisseria meningitidis (4CMenB) at 6, 8 and 12 months of age produced serum bacterici...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Snape, MD, Philip, J, John, T, Robinson, H, Kelly, S, Gossger, N, Yu, L, Kittel, C, Toneatto, D, Dull, P, Pollard, A
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: 2013